Summary.-Over the past 70 years many experiments have been designed to promote tumour growth. These studies were all carried out in allogeneic tumour systems or by artificially influencing the immunization process.
In the present study, the growth of syngeneic mammary tumour cells was enhanced by prior immunization via the intracaecal route. Such induced enhancement could be transferred to untreated animals by serum or by spleen cells.
Tumour growth was also enhanced in another syngeneic system by immunization via the intestinal route with frozen-thawed ascites tumour cells. The result is in direct contrast to that obtained by similar immunization with live cells, which affords protection against a later challenge.
MANY STUDIES performed over the last 70 years have been designed to elicit tumour resistance after the injection of inactivated tumour cells.
In several instances the results were the opposite of those anticipated; that is, tumour growth was promoted rather than inhibited by prior immunization.
The phenomenon of enhancement was first observed by Flexner and Jobling (1907) who found that the growth of a transplantable sarcoma in rats was encouraged if the hosts had been given a prior injection of tumour cells heated for half an hour at 56°C. The effect was pronounced when the heated tumour cells were injected s.c. several times before challenge with live cells.
A great many studies have since been made. These early experiments were repeated and confirmed by Snell et al. (1946) and Snell (1970) . Kaliss (1952 Kaliss ( , 1958 passively transferred this specific tumour susceptibility with serum from treated animals. He called the phenomenon "immunological enhancement", defining it as the successful establishment of a tumour homograft and its progressive growth as a consequence of the tumour's contact with specific antiserum in the host. Kaliss leaves no doubt that specific antibodies play a fundamental role in the induction of enhancement. He worked, however, with allogeneic tumours. It has been extremely difficult to reproduce this phenomenon with syngeneic tumours. By changing the test system, however, Moller (1964) found that treatment with immune serum enhanced the growth of chemically induced syngeneic murine sarcomas. Attia and Weiss (1966) were also able to enhance the growth of spontaneous mammary carcinomas by pretreatment with tumour cell-membrane concentrate, but only if the first inoculation was given in complete Freund's adjuvant. Takasugi and Hildemann (1969) found, when antiserum fractions were tested in vivo, that only IgGy2 was capable of enhancing tumour growth.
In accordance with this, Ran and XVitz (1972) (Laursen and Laursen, 1977) . In further studies we have also found that growth of a subsequient graft could be enhanced in this way.
The present report describes the enhancement of growth of spontaneous syngeneic mammary carcinoma cells by prior immunization via the intracaecal route with the same cells, without other treatments.
Enhancement of tumour growth is also induced in another syngeneic system by immunization via the intestinal route with frozen-thawed ascites tumour cells, and this increased tumour susceptibility is passively transferred with serum and spleen cells to untreated animals. This is in direct contrast to our results (Laursen and Laursen, 1977) obtained by immunization in the same way, but with live cells, where protection was afforded against a later challenge.
MATERIALS AND METHODS
Eight-to 10-wieek-old inbred mice of the C3H-Fib strain were used for this work. The animals were kept under conventional conditions with up to 10 mice in each cage. The mice were maintained on a standard pellet diet and water ad libitumn.
Malignant material of two types was used. One was a spontaneous mammary carcinoma which originated in a C3H-Fib mouse and -was passed serially by the s. Tumour volumes were estimated from the formula, V = 0 4 ab2, where a is the major diameter and b the minor diameter, as proposed by Attia and Weiss (1966 Table III shows the results of experiments where enhancement was adoptively transferred to untreated C3H mice with serum or spleen cells from C3H mice immunized twice intracaecally (with a oneweek interval) with mammary tumour cells.
By transferring 0-2 ml serum 1 h before the s.c. challenge and again 2 and 4 days later, tumour growth was enhanced; a mean tumour volume of 2-32 cm3 was recorded 27 days later, whereas tumours in the untreated group had grown only to a mean of 1-37 cm3. A stronger enhancement was noticed after transfer of spleen cells 1 h before challenge. The s.c. transplant in this group then grew to a mean volume of 3 09 cm3, which may again be compared with the aforementioned 1'37 cm3 for controls. (1958) found, in sublines of ascites sarcoma cells, a direct correlation between the negative surface charge of the cells, as indicated by migration in an electric field, and the degree of invasiveness exhibited in the animal. The ascites form had the hiighest electrophoretic mobility, whilst the solid line of the tumour had the lowest.
In the present study, the live ascites cell should then be best able to migrate into the intestinal wall, and might even leave this wall via the efferent lymphatics. Frozen-thawed cells and mitomycin-Ctreated cells, however, do not have this ability to the same degree. As the distribution of Ig-containing cells is not homogeneous throughout the depth of the intestinal wall, it is rendered probable that the immune response differs according to whether sensitization takes place in the mesenteric lymph node, deep in the intestinal wall or in lymphoid cells placed near the lumen.
According to such hypotheses, enhancement should be induced in the intestinal wall by the most luminally placed components of the immune system.
The mammary tumour cells (MTC) originated as a solid tumour and, according to the findings by Purdom et al. (1958) , had a lesser ability to migrate than had the live ascites cells. Furthermore, the MTC suspension used in this study was a mixture of live and dead cells. By immunizing with this suspension a balanced, or at least partially balanced response should result. In our experiments, the enhancing effect dominated.
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